nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—TLR7—systemic lupus erythematosus	0.634	1	CbGaD
Imiquimod—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0304	0.255	CbGbCtD
Imiquimod—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.013	0.109	CbGbCtD
Imiquimod—CYP3A4—Dapsone—systemic lupus erythematosus	0.0114	0.0951	CbGbCtD
Imiquimod—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00985	0.0825	CbGbCtD
Imiquimod—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00985	0.0825	CbGbCtD
Imiquimod—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00845	0.0708	CbGbCtD
Imiquimod—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00834	0.0698	CbGbCtD
Imiquimod—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00791	0.0662	CbGbCtD
Imiquimod—CYP3A4—Prednisone—systemic lupus erythematosus	0.00788	0.0659	CbGbCtD
Imiquimod—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00747	0.0625	CbGbCtD
Imiquimod—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00492	0.0412	CbGbCtD
Imiquimod—TLR8—lymphoid tissue—systemic lupus erythematosus	0.00323	0.16	CbGeAlD
Imiquimod—TLR8—bone marrow—systemic lupus erythematosus	0.00294	0.145	CbGeAlD
Imiquimod—TLR8—lung—systemic lupus erythematosus	0.00267	0.132	CbGeAlD
Imiquimod—TLR7—lymphoid tissue—systemic lupus erythematosus	0.00204	0.101	CbGeAlD
Imiquimod—TLR7—tendon—systemic lupus erythematosus	0.00192	0.0947	CbGeAlD
Imiquimod—CYP1A2—urine—systemic lupus erythematosus	0.00181	0.0893	CbGeAlD
Imiquimod—TLR7—lung—systemic lupus erythematosus	0.00168	0.0831	CbGeAlD
Imiquimod—CYP3A4—urine—systemic lupus erythematosus	0.00131	0.0646	CbGeAlD
Imiquimod—CYP1A2—blood plasma—systemic lupus erythematosus	0.000943	0.0466	CbGeAlD
Imiquimod—CYP3A4—blood plasma—systemic lupus erythematosus	0.000682	0.0337	CbGeAlD
Imiquimod—CYP3A4—kidney—systemic lupus erythematosus	0.000309	0.0153	CbGeAlD
Imiquimod—CYP1A2—lung—systemic lupus erythematosus	0.000303	0.015	CbGeAlD
Imiquimod—TLR8—Innate Immune System—FCGR3A—systemic lupus erythematosus	0.000212	0.00195	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—RIPK1—systemic lupus erythematosus	0.000209	0.00192	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—TYK2—systemic lupus erythematosus	0.000206	0.00189	CbGpPWpGaD
Imiquimod—CYP3A4—nervous system—systemic lupus erythematosus	0.000203	0.01	CbGeAlD
Imiquimod—TLR7—Innate Immune System—C4B—systemic lupus erythematosus	0.000202	0.00186	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—C4A—systemic lupus erythematosus	0.000202	0.00186	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TLR9—systemic lupus erythematosus	0.000202	0.00186	CbGpPWpGaD
Imiquimod—CYP3A4—central nervous system—systemic lupus erythematosus	0.000195	0.00966	CbGeAlD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TYK2—systemic lupus erythematosus	0.000193	0.00178	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—systemic lupus erythematosus	0.00019	0.00175	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—XRCC6—systemic lupus erythematosus	0.00019	0.00174	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TLR4—systemic lupus erythematosus	0.000188	0.00173	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TREX1—systemic lupus erythematosus	0.000183	0.00168	CbGpPWpGaD
Imiquimod—TLR8—Immune System—KLRK1—systemic lupus erythematosus	0.000183	0.00168	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD226—systemic lupus erythematosus	0.000183	0.00168	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CR1—systemic lupus erythematosus	0.00018	0.00165	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MBL2—systemic lupus erythematosus	0.000179	0.00164	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CD80—systemic lupus erythematosus	0.000176	0.00161	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CFB—systemic lupus erythematosus	0.000172	0.00158	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TLR6—systemic lupus erythematosus	0.000172	0.00158	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TLR5—systemic lupus erythematosus	0.000172	0.00158	CbGpPWpGaD
Imiquimod—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000171	0.00157	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ITGAM—systemic lupus erythematosus	0.000169	0.00156	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IFIH1—systemic lupus erythematosus	0.000169	0.00156	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CD247—systemic lupus erythematosus	0.000169	0.00156	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FCGR2B—systemic lupus erythematosus	0.000167	0.00153	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—LYN—systemic lupus erythematosus	0.000164	0.0015	CbGpPWpGaD
Imiquimod—TLR7—Immune System—C1S—systemic lupus erythematosus	0.000163	0.00149	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TRIM21—systemic lupus erythematosus	0.000163	0.00149	CbGpPWpGaD
Imiquimod—TLR7—Immune System—C1R—systemic lupus erythematosus	0.000163	0.00149	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RASGRP3—systemic lupus erythematosus	0.000163	0.00149	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TLR10—systemic lupus erythematosus	0.000163	0.00149	CbGpPWpGaD
Imiquimod—TLR8—Immune System—C1QA—systemic lupus erythematosus	0.000163	0.00149	CbGpPWpGaD
Imiquimod—TLR8—Immune System—UBE2L3—systemic lupus erythematosus	0.000163	0.00149	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—FCGR2A—systemic lupus erythematosus	0.000161	0.00148	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FCGR3A—systemic lupus erythematosus	0.00016	0.00147	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—RIPK1—systemic lupus erythematosus	0.000158	0.00146	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TNFAIP3—systemic lupus erythematosus	0.000158	0.00146	CbGpPWpGaD
Imiquimod—TLR8—Immune System—C4A—systemic lupus erythematosus	0.000155	0.00143	CbGpPWpGaD
Imiquimod—TLR8—Immune System—C4B—systemic lupus erythematosus	0.000155	0.00143	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TLR9—systemic lupus erythematosus	0.000153	0.00141	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—systemic lupus erythematosus	0.000152	0.0014	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PDCD1—systemic lupus erythematosus	0.000149	0.00137	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TLR7—systemic lupus erythematosus	0.000149	0.00137	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TYK2—systemic lupus erythematosus	0.000147	0.00135	CbGpPWpGaD
Imiquimod—TLR8—Immune System—XRCC6—systemic lupus erythematosus	0.000146	0.00134	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—systemic lupus erythematosus	0.00014	0.00129	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KLRK1—systemic lupus erythematosus	0.000138	0.00127	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD226—systemic lupus erythematosus	0.000138	0.00127	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CR1—systemic lupus erythematosus	0.000138	0.00127	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—systemic lupus erythematosus	0.000138	0.00127	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MBL2—systemic lupus erythematosus	0.000135	0.00124	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—systemic lupus erythematosus	0.000133	0.00122	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CFB—systemic lupus erythematosus	0.000132	0.00121	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TLR6—systemic lupus erythematosus	0.000132	0.00121	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TLR5—systemic lupus erythematosus	0.00013	0.0012	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—HMGB1—systemic lupus erythematosus	0.000128	0.00118	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IFIH1—systemic lupus erythematosus	0.000128	0.00118	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—ITGAM—systemic lupus erythematosus	0.000128	0.00118	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CD247—systemic lupus erythematosus	0.000128	0.00118	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FCGR2B—systemic lupus erythematosus	0.000127	0.00116	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IFNA1—systemic lupus erythematosus	0.000126	0.00116	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—LYN—systemic lupus erythematosus	0.000124	0.00114	CbGpPWpGaD
Imiquimod—TLR7—Immune System—UBE2L3—systemic lupus erythematosus	0.000123	0.00113	CbGpPWpGaD
Imiquimod—TLR7—Immune System—C1QA—systemic lupus erythematosus	0.000123	0.00113	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FCGR3A—systemic lupus erythematosus	0.000123	0.00113	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—RASGRP1—systemic lupus erythematosus	0.000123	0.00113	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—systemic lupus erythematosus	0.000123	0.00113	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FCGR2A—systemic lupus erythematosus	0.000122	0.00112	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RIPK1—systemic lupus erythematosus	0.000122	0.00112	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TNFAIP3—systemic lupus erythematosus	0.00012	0.0011	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—systemic lupus erythematosus	0.000119	0.00109	CbGpPWpGaD
Imiquimod—TLR7—Immune System—C4B—systemic lupus erythematosus	0.000118	0.00108	CbGpPWpGaD
Imiquimod—TLR7—Immune System—C4A—systemic lupus erythematosus	0.000118	0.00108	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TLR9—systemic lupus erythematosus	0.000118	0.00108	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—systemic lupus erythematosus	0.000115	0.00106	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PDCD1—systemic lupus erythematosus	0.000113	0.00104	CbGpPWpGaD
Imiquimod—TLR7—Immune System—XRCC6—systemic lupus erythematosus	0.000111	0.00102	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—systemic lupus erythematosus	0.000106	0.000978	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CR1—systemic lupus erythematosus	0.000105	0.000963	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CSK—systemic lupus erythematosus	0.000105	0.000963	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—systemic lupus erythematosus	0.000105	0.00096	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MBL2—systemic lupus erythematosus	0.000104	0.000955	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRF5—systemic lupus erythematosus	0.000103	0.000948	CbGpPWpGaD
Imiquimod—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000102	0.00094	CbGpPWpGaD
Imiquimod—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000101	0.000931	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—systemic lupus erythematosus	0.000101	0.000927	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TLR6—systemic lupus erythematosus	0.0001	0.000919	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CFB—systemic lupus erythematosus	0.0001	0.000919	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ITGAM—systemic lupus erythematosus	9.86e-05	0.000906	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD247—systemic lupus erythematosus	9.86e-05	0.000906	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFIH1—systemic lupus erythematosus	9.86e-05	0.000906	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRF8—systemic lupus erythematosus	9.86e-05	0.000906	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HMGB1—systemic lupus erythematosus	9.72e-05	0.000893	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NCF2—systemic lupus erythematosus	9.59e-05	0.000881	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—systemic lupus erythematosus	9.57e-05	0.000879	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IFNA1—systemic lupus erythematosus	9.55e-05	0.000878	CbGpPWpGaD
Imiquimod—TLR8—Immune System—LYN—systemic lupus erythematosus	9.53e-05	0.000875	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—JAK1—systemic lupus erythematosus	9.52e-05	0.000875	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—systemic lupus erythematosus	9.46e-05	0.000869	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FCGR2A—systemic lupus erythematosus	9.4e-05	0.000864	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FCGR3A—systemic lupus erythematosus	9.35e-05	0.000859	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—RASGRP1—systemic lupus erythematosus	9.3e-05	0.000855	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—systemic lupus erythematosus	9.29e-05	0.000853	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RIPK1—systemic lupus erythematosus	9.23e-05	0.000848	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TNFAIP3—systemic lupus erythematosus	9.23e-05	0.000848	CbGpPWpGaD
Imiquimod—TLR8—Immune System—BLK—systemic lupus erythematosus	9.12e-05	0.000838	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—systemic lupus erythematosus	8.98e-05	0.000825	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TLR9—systemic lupus erythematosus	8.92e-05	0.000819	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—C3—systemic lupus erythematosus	8.82e-05	0.00081	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CRP—systemic lupus erythematosus	8.39e-05	0.000771	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PTPRC—systemic lupus erythematosus	8.15e-05	0.000749	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1RN—systemic lupus erythematosus	8.12e-05	0.000746	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TLR4—systemic lupus erythematosus	8.04e-05	0.000739	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CSK—systemic lupus erythematosus	7.95e-05	0.00073	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MBL2—systemic lupus erythematosus	7.88e-05	0.000724	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	7.88e-05	0.000724	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRF5—systemic lupus erythematosus	7.82e-05	0.000718	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD40—systemic lupus erythematosus	7.58e-05	0.000696	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	7.54e-05	0.000693	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRF8—systemic lupus erythematosus	7.47e-05	0.000686	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD247—systemic lupus erythematosus	7.47e-05	0.000686	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFIH1—systemic lupus erythematosus	7.47e-05	0.000686	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ITGAM—systemic lupus erythematosus	7.47e-05	0.000686	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CTLA4—systemic lupus erythematosus	7.47e-05	0.000686	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HMGB1—systemic lupus erythematosus	7.47e-05	0.000686	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	7.46e-05	0.000685	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CD80—systemic lupus erythematosus	7.42e-05	0.000682	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNA1—systemic lupus erythematosus	7.34e-05	0.000674	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NCF2—systemic lupus erythematosus	7.27e-05	0.000668	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—systemic lupus erythematosus	7.25e-05	0.000666	CbGpPWpGaD
Imiquimod—TLR7—Immune System—LYN—systemic lupus erythematosus	7.22e-05	0.000663	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—JAK1—systemic lupus erythematosus	7.22e-05	0.000663	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—systemic lupus erythematosus	7.17e-05	0.000659	CbGpPWpGaD
Imiquimod—TLR8—Immune System—RASGRP1—systemic lupus erythematosus	7.15e-05	0.000657	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FCGR2A—systemic lupus erythematosus	7.13e-05	0.000655	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD79A—systemic lupus erythematosus	7.13e-05	0.000655	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TNFAIP3—systemic lupus erythematosus	7e-05	0.000643	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	6.94e-05	0.000638	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PRL—systemic lupus erythematosus	6.93e-05	0.000637	CbGpPWpGaD
Imiquimod—TLR7—Immune System—BLK—systemic lupus erythematosus	6.91e-05	0.000635	CbGpPWpGaD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	6.75e-05	0.00062	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—C3—systemic lupus erythematosus	6.68e-05	0.000614	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-DQA1—systemic lupus erythematosus	6.58e-05	0.000604	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CRP—systemic lupus erythematosus	6.36e-05	0.000584	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TYK2—systemic lupus erythematosus	6.26e-05	0.000576	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTPRC—systemic lupus erythematosus	6.18e-05	0.000568	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1RN—systemic lupus erythematosus	6.15e-05	0.000565	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-DQB1—systemic lupus erythematosus	6.15e-05	0.000565	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TLR4—systemic lupus erythematosus	6.09e-05	0.00056	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL18—systemic lupus erythematosus	5.83e-05	0.000536	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	5.82e-05	0.000535	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD40LG—systemic lupus erythematosus	5.81e-05	0.000534	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD40—systemic lupus erythematosus	5.75e-05	0.000528	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD8A—systemic lupus erythematosus	5.75e-05	0.000528	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CD4—systemic lupus erythematosus	5.67e-05	0.00052	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CTLA4—systemic lupus erythematosus	5.66e-05	0.00052	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HMGB1—systemic lupus erythematosus	5.66e-05	0.00052	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CD80—systemic lupus erythematosus	5.62e-05	0.000517	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNA1—systemic lupus erythematosus	5.56e-05	0.000511	CbGpPWpGaD
Imiquimod—TLR8—Immune System—JAK1—systemic lupus erythematosus	5.55e-05	0.000509	CbGpPWpGaD
Imiquimod—TLR7—Immune System—RASGRP1—systemic lupus erythematosus	5.42e-05	0.000498	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD79A—systemic lupus erythematosus	5.4e-05	0.000496	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CDKN1B—systemic lupus erythematosus	5.33e-05	0.000489	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	5.29e-05	0.000486	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	5.26e-05	0.000483	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PRL—systemic lupus erythematosus	5.25e-05	0.000483	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL2RA—systemic lupus erythematosus	5.18e-05	0.000476	CbGpPWpGaD
Imiquimod—TLR8—Immune System—C3—systemic lupus erythematosus	5.13e-05	0.000472	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-DQA1—systemic lupus erythematosus	4.98e-05	0.000458	CbGpPWpGaD
Imiquimod—Discomfort—Betamethasone—systemic lupus erythematosus	4.98e-05	0.000425	CcSEcCtD
Imiquimod—Discomfort—Dexamethasone—systemic lupus erythematosus	4.98e-05	0.000425	CcSEcCtD
Imiquimod—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	4.98e-05	0.000425	CcSEcCtD
Imiquimod—Haemoglobin—Methotrexate—systemic lupus erythematosus	4.98e-05	0.000425	CcSEcCtD
Imiquimod—Pain—Prednisolone—systemic lupus erythematosus	4.96e-05	0.000423	CcSEcCtD
Imiquimod—Haemorrhage—Methotrexate—systemic lupus erythematosus	4.95e-05	0.000423	CcSEcCtD
Imiquimod—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	4.94e-05	0.000421	CcSEcCtD
Imiquimod—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	4.92e-05	0.00042	CcSEcCtD
Imiquimod—Pharyngitis—Methotrexate—systemic lupus erythematosus	4.92e-05	0.00042	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CDKN1A—systemic lupus erythematosus	4.92e-05	0.000452	CbGpPWpGaD
Imiquimod—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.91e-05	0.000419	CcSEcCtD
Imiquimod—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.91e-05	0.000419	CcSEcCtD
Imiquimod—Nausea—Leflunomide—systemic lupus erythematosus	4.9e-05	0.000418	CcSEcCtD
Imiquimod—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	4.89e-05	0.000417	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.89e-05	0.000417	CcSEcCtD
Imiquimod—TLR8—Immune System—CRP—systemic lupus erythematosus	4.88e-05	0.000449	CbGpPWpGaD
Imiquimod—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.88e-05	0.000416	CcSEcCtD
Imiquimod—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.86e-05	0.000414	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.86e-05	0.000414	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.85e-05	0.000413	CcSEcCtD
Imiquimod—Pain—Hydrocortisone—systemic lupus erythematosus	4.84e-05	0.000413	CcSEcCtD
Imiquimod—Oedema—Dexamethasone—systemic lupus erythematosus	4.84e-05	0.000413	CcSEcCtD
Imiquimod—Oedema—Betamethasone—systemic lupus erythematosus	4.84e-05	0.000413	CcSEcCtD
Imiquimod—Insomnia—Triamcinolone—systemic lupus erythematosus	4.82e-05	0.000411	CcSEcCtD
Imiquimod—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.81e-05	0.00041	CcSEcCtD
Imiquimod—Infection—Dexamethasone—systemic lupus erythematosus	4.8e-05	0.00041	CcSEcCtD
Imiquimod—Infection—Betamethasone—systemic lupus erythematosus	4.8e-05	0.00041	CcSEcCtD
Imiquimod—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.79e-05	0.000409	CcSEcCtD
Imiquimod—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.79e-05	0.000408	CcSEcCtD
Imiquimod—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.78e-05	0.000408	CcSEcCtD
Imiquimod—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.78e-05	0.000407	CcSEcCtD
Imiquimod—Visual impairment—Methotrexate—systemic lupus erythematosus	4.77e-05	0.000407	CcSEcCtD
Imiquimod—Shock—Dexamethasone—systemic lupus erythematosus	4.76e-05	0.000406	CcSEcCtD
Imiquimod—Shock—Betamethasone—systemic lupus erythematosus	4.76e-05	0.000406	CcSEcCtD
Imiquimod—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.75e-05	0.000405	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—TYK2—systemic lupus erythematosus	4.75e-05	0.000436	CbGpPWpGaD
Imiquimod—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.74e-05	0.000405	CcSEcCtD
Imiquimod—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.74e-05	0.000405	CcSEcCtD
Imiquimod—Agitation—Prednisone—systemic lupus erythematosus	4.74e-05	0.000405	CcSEcCtD
Imiquimod—Tachycardia—Dexamethasone—systemic lupus erythematosus	4.72e-05	0.000403	CcSEcCtD
Imiquimod—Tachycardia—Betamethasone—systemic lupus erythematosus	4.72e-05	0.000403	CcSEcCtD
Imiquimod—Angioedema—Prednisone—systemic lupus erythematosus	4.72e-05	0.000402	CcSEcCtD
Imiquimod—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	4.69e-05	0.0004	CcSEcCtD
Imiquimod—Dyspepsia—Triamcinolone—systemic lupus erythematosus	4.69e-05	0.0004	CcSEcCtD
Imiquimod—Erythema multiforme—Methotrexate—systemic lupus erythematosus	4.68e-05	0.0004	CcSEcCtD
Imiquimod—TLR8—Immune System—TLR4—systemic lupus erythematosus	4.68e-05	0.00043	CbGpPWpGaD
Imiquimod—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	4.68e-05	0.000399	CcSEcCtD
Imiquimod—TLR8—Immune System—HLA-DRB1—systemic lupus erythematosus	4.68e-05	0.00043	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—EP300—systemic lupus erythematosus	4.68e-05	0.00043	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	4.68e-05	0.000399	CcSEcCtD
Imiquimod—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	4.68e-05	0.000399	CcSEcCtD
Imiquimod—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	4.66e-05	0.000398	CcSEcCtD
Imiquimod—TLR7—Immune System—HLA-DQB1—systemic lupus erythematosus	4.66e-05	0.000428	CbGpPWpGaD
Imiquimod—Malaise—Prednisone—systemic lupus erythematosus	4.65e-05	0.000397	CcSEcCtD
Imiquimod—Eye disorder—Methotrexate—systemic lupus erythematosus	4.63e-05	0.000395	CcSEcCtD
Imiquimod—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	4.63e-05	0.000395	CcSEcCtD
Imiquimod—Syncope—Prednisone—systemic lupus erythematosus	4.63e-05	0.000395	CcSEcCtD
Imiquimod—Tinnitus—Methotrexate—systemic lupus erythematosus	4.62e-05	0.000394	CcSEcCtD
Imiquimod—Anorexia—Dexamethasone—systemic lupus erythematosus	4.61e-05	0.000393	CcSEcCtD
Imiquimod—Anorexia—Betamethasone—systemic lupus erythematosus	4.61e-05	0.000393	CcSEcCtD
Imiquimod—Urticaria—Prednisolone—systemic lupus erythematosus	4.6e-05	0.000393	CcSEcCtD
Imiquimod—Fatigue—Triamcinolone—systemic lupus erythematosus	4.6e-05	0.000392	CcSEcCtD
Imiquimod—Fatigue—Methylprednisolone—systemic lupus erythematosus	4.59e-05	0.000391	CcSEcCtD
Imiquimod—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	4.58e-05	0.000391	CcSEcCtD
Imiquimod—Asthenia—Cyclosporine—systemic lupus erythematosus	4.57e-05	0.00039	CcSEcCtD
Imiquimod—Pain—Triamcinolone—systemic lupus erythematosus	4.56e-05	0.000389	CcSEcCtD
Imiquimod—Loss of consciousness—Prednisone—systemic lupus erythematosus	4.54e-05	0.000387	CcSEcCtD
Imiquimod—Pruritus—Cyclosporine—systemic lupus erythematosus	4.51e-05	0.000384	CcSEcCtD
Imiquimod—Urticaria—Hydrocortisone—systemic lupus erythematosus	4.5e-05	0.000384	CcSEcCtD
Imiquimod—Angiopathy—Methotrexate—systemic lupus erythematosus	4.49e-05	0.000384	CcSEcCtD
Imiquimod—Immune system disorder—Methotrexate—systemic lupus erythematosus	4.47e-05	0.000382	CcSEcCtD
Imiquimod—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	4.47e-05	0.000382	CcSEcCtD
Imiquimod—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	4.47e-05	0.000382	CcSEcCtD
Imiquimod—Convulsion—Prednisone—systemic lupus erythematosus	4.47e-05	0.000381	CcSEcCtD
Imiquimod—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	4.47e-05	0.000381	CcSEcCtD
Imiquimod—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	4.46e-05	0.00038	CcSEcCtD
Imiquimod—Hypertension—Prednisone—systemic lupus erythematosus	4.46e-05	0.00038	CcSEcCtD
Imiquimod—Chills—Methotrexate—systemic lupus erythematosus	4.45e-05	0.000379	CcSEcCtD
Imiquimod—TLR7—Immune System—IL18—systemic lupus erythematosus	4.42e-05	0.000406	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	4.41e-05	0.000376	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	4.41e-05	0.000376	CcSEcCtD
Imiquimod—TLR7—Immune System—CD40LG—systemic lupus erythematosus	4.4e-05	0.000405	CbGpPWpGaD
Imiquimod—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	4.4e-05	0.000375	CcSEcCtD
Imiquimod—Myalgia—Prednisone—systemic lupus erythematosus	4.39e-05	0.000375	CcSEcCtD
Imiquimod—Arthralgia—Prednisone—systemic lupus erythematosus	4.39e-05	0.000375	CcSEcCtD
Imiquimod—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	4.39e-05	0.000375	CcSEcCtD
Imiquimod—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	4.38e-05	0.000374	CcSEcCtD
Imiquimod—Anxiety—Prednisone—systemic lupus erythematosus	4.38e-05	0.000374	CcSEcCtD
Imiquimod—Alopecia—Methotrexate—systemic lupus erythematosus	4.38e-05	0.000374	CcSEcCtD
Imiquimod—Insomnia—Dexamethasone—systemic lupus erythematosus	4.37e-05	0.000373	CcSEcCtD
Imiquimod—Insomnia—Betamethasone—systemic lupus erythematosus	4.37e-05	0.000373	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	4.36e-05	0.000372	CcSEcCtD
Imiquimod—Diarrhoea—Cyclosporine—systemic lupus erythematosus	4.36e-05	0.000372	CcSEcCtD
Imiquimod—TLR7—Immune System—CD8A—systemic lupus erythematosus	4.35e-05	0.0004	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	4.35e-05	0.000371	CcSEcCtD
Imiquimod—Paraesthesia—Dexamethasone—systemic lupus erythematosus	4.34e-05	0.000371	CcSEcCtD
Imiquimod—Paraesthesia—Betamethasone—systemic lupus erythematosus	4.34e-05	0.000371	CcSEcCtD
Imiquimod—Discomfort—Prednisone—systemic lupus erythematosus	4.34e-05	0.00037	CcSEcCtD
Imiquimod—Mental disorder—Methotrexate—systemic lupus erythematosus	4.34e-05	0.00037	CcSEcCtD
Imiquimod—TLR8—Immune System—CD80—systemic lupus erythematosus	4.32e-05	0.000397	CbGpPWpGaD
Imiquimod—Erythema—Methotrexate—systemic lupus erythematosus	4.31e-05	0.000368	CcSEcCtD
Imiquimod—Malnutrition—Methotrexate—systemic lupus erythematosus	4.31e-05	0.000368	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CD4—systemic lupus erythematosus	4.29e-05	0.000394	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	4.29e-05	0.000394	CbGpPWpGaD
Imiquimod—Hypersensitivity—Prednisolone—systemic lupus erythematosus	4.27e-05	0.000364	CcSEcCtD
Imiquimod—Dyspepsia—Betamethasone—systemic lupus erythematosus	4.26e-05	0.000363	CcSEcCtD
Imiquimod—Dyspepsia—Dexamethasone—systemic lupus erythematosus	4.26e-05	0.000363	CcSEcCtD
Imiquimod—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	4.25e-05	0.000363	CcSEcCtD
Imiquimod—Urticaria—Triamcinolone—systemic lupus erythematosus	4.23e-05	0.000361	CcSEcCtD
Imiquimod—Urticaria—Methylprednisolone—systemic lupus erythematosus	4.22e-05	0.00036	CcSEcCtD
Imiquimod—Body temperature increased—Triamcinolone—systemic lupus erythematosus	4.21e-05	0.000359	CcSEcCtD
Imiquimod—Dizziness—Cyclosporine—systemic lupus erythematosus	4.21e-05	0.000359	CcSEcCtD
Imiquimod—Oedema—Prednisone—systemic lupus erythematosus	4.21e-05	0.000359	CcSEcCtD
Imiquimod—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	4.2e-05	0.000359	CcSEcCtD
Imiquimod—Decreased appetite—Betamethasone—systemic lupus erythematosus	4.2e-05	0.000359	CcSEcCtD
Imiquimod—Decreased appetite—Dexamethasone—systemic lupus erythematosus	4.2e-05	0.000359	CcSEcCtD
Imiquimod—TLR7—Immune System—JAK1—systemic lupus erythematosus	4.2e-05	0.000386	CbGpPWpGaD
Imiquimod—Infection—Prednisone—systemic lupus erythematosus	4.18e-05	0.000357	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	4.18e-05	0.000356	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	4.18e-05	0.000356	CcSEcCtD
Imiquimod—Back pain—Methotrexate—systemic lupus erythematosus	4.17e-05	0.000356	CcSEcCtD
Imiquimod—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	4.17e-05	0.000356	CcSEcCtD
Imiquimod—Fatigue—Betamethasone—systemic lupus erythematosus	4.17e-05	0.000356	CcSEcCtD
Imiquimod—Fatigue—Dexamethasone—systemic lupus erythematosus	4.17e-05	0.000356	CcSEcCtD
Imiquimod—Shock—Prednisone—systemic lupus erythematosus	4.14e-05	0.000354	CcSEcCtD
Imiquimod—Pain—Betamethasone—systemic lupus erythematosus	4.14e-05	0.000353	CcSEcCtD
Imiquimod—Pain—Dexamethasone—systemic lupus erythematosus	4.14e-05	0.000353	CcSEcCtD
Imiquimod—Nervous system disorder—Prednisone—systemic lupus erythematosus	4.13e-05	0.000352	CcSEcCtD
Imiquimod—Tachycardia—Prednisone—systemic lupus erythematosus	4.11e-05	0.000351	CcSEcCtD
Imiquimod—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	4.11e-05	0.000351	CcSEcCtD
Imiquimod—Skin disorder—Prednisone—systemic lupus erythematosus	4.09e-05	0.000349	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4.08e-05	0.000375	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Prednisone—systemic lupus erythematosus	4.07e-05	0.000347	CcSEcCtD
Imiquimod—Asthenia—Hydrocortisone—systemic lupus erythematosus	4.06e-05	0.000347	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	4.06e-05	0.000373	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	4.06e-05	0.000373	CbGpPWpGaD
Imiquimod—Vomiting—Cyclosporine—systemic lupus erythematosus	4.05e-05	0.000346	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CDKN1B—systemic lupus erythematosus	4.04e-05	0.000371	CbGpPWpGaD
Imiquimod—Rash—Cyclosporine—systemic lupus erythematosus	4.02e-05	0.000343	CcSEcCtD
Imiquimod—Anorexia—Prednisone—systemic lupus erythematosus	4.01e-05	0.000343	CcSEcCtD
Imiquimod—Dermatitis—Cyclosporine—systemic lupus erythematosus	4.01e-05	0.000342	CcSEcCtD
Imiquimod—Pruritus—Hydrocortisone—systemic lupus erythematosus	4e-05	0.000342	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	4e-05	0.000368	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	4e-05	0.000341	CcSEcCtD
Imiquimod—Headache—Cyclosporine—systemic lupus erythematosus	3.99e-05	0.00034	CcSEcCtD
Imiquimod—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.99e-05	0.00034	CcSEcCtD
Imiquimod—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.99e-05	0.00034	CcSEcCtD
Imiquimod—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.95e-05	0.000337	CcSEcCtD
Imiquimod—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.95e-05	0.000337	CcSEcCtD
Imiquimod—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.95e-05	0.000337	CcSEcCtD
Imiquimod—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.93e-05	0.000335	CcSEcCtD
Imiquimod—TLR7—Immune System—IL2RA—systemic lupus erythematosus	3.92e-05	0.000361	CbGpPWpGaD
Imiquimod—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.92e-05	0.000334	CcSEcCtD
Imiquimod—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.92e-05	0.000334	CcSEcCtD
Imiquimod—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.91e-05	0.000334	CcSEcCtD
Imiquimod—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.89e-05	0.000332	CcSEcCtD
Imiquimod—TLR7—Immune System—C3—systemic lupus erythematosus	3.89e-05	0.000358	CbGpPWpGaD
Imiquimod—Malaise—Methotrexate—systemic lupus erythematosus	3.89e-05	0.000332	CcSEcCtD
Imiquimod—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.87e-05	0.00033	CcSEcCtD
Imiquimod—Urticaria—Dexamethasone—systemic lupus erythematosus	3.84e-05	0.000328	CcSEcCtD
Imiquimod—Urticaria—Betamethasone—systemic lupus erythematosus	3.84e-05	0.000328	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.84e-05	0.000327	CcSEcCtD
Imiquimod—Dizziness—Prednisolone—systemic lupus erythematosus	3.83e-05	0.000327	CcSEcCtD
Imiquimod—Asthenia—Triamcinolone—systemic lupus erythematosus	3.82e-05	0.000326	CcSEcCtD
Imiquimod—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.82e-05	0.000326	CcSEcCtD
Imiquimod—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.82e-05	0.000326	CcSEcCtD
Imiquimod—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.82e-05	0.000326	CcSEcCtD
Imiquimod—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.82e-05	0.000326	CcSEcCtD
Imiquimod—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.82e-05	0.000326	CcSEcCtD
Imiquimod—Insomnia—Prednisone—systemic lupus erythematosus	3.81e-05	0.000325	CcSEcCtD
Imiquimod—Nausea—Cyclosporine—systemic lupus erythematosus	3.78e-05	0.000323	CcSEcCtD
Imiquimod—Paraesthesia—Prednisone—systemic lupus erythematosus	3.78e-05	0.000323	CcSEcCtD
Imiquimod—Pruritus—Triamcinolone—systemic lupus erythematosus	3.77e-05	0.000322	CcSEcCtD
Imiquimod—Cough—Methotrexate—systemic lupus erythematosus	3.76e-05	0.000321	CcSEcCtD
Imiquimod—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.76e-05	0.000321	CcSEcCtD
Imiquimod—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.74e-05	0.000319	CcSEcCtD
Imiquimod—Convulsion—Methotrexate—systemic lupus erythematosus	3.74e-05	0.000319	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CDKN1A—systemic lupus erythematosus	3.73e-05	0.000342	CbGpPWpGaD
Imiquimod—Dyspepsia—Prednisone—systemic lupus erythematosus	3.71e-05	0.000316	CcSEcCtD
Imiquimod—TLR7—Immune System—CRP—systemic lupus erythematosus	3.7e-05	0.00034	CbGpPWpGaD
Imiquimod—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.69e-05	0.000315	CcSEcCtD
Imiquimod—Chest pain—Methotrexate—systemic lupus erythematosus	3.67e-05	0.000313	CcSEcCtD
Imiquimod—Myalgia—Methotrexate—systemic lupus erythematosus	3.67e-05	0.000313	CcSEcCtD
Imiquimod—Arthralgia—Methotrexate—systemic lupus erythematosus	3.67e-05	0.000313	CcSEcCtD
Imiquimod—Decreased appetite—Prednisone—systemic lupus erythematosus	3.66e-05	0.000312	CcSEcCtD
Imiquimod—Rash—Prednisolone—systemic lupus erythematosus	3.65e-05	0.000312	CcSEcCtD
Imiquimod—Dermatitis—Prednisolone—systemic lupus erythematosus	3.65e-05	0.000312	CcSEcCtD
Imiquimod—TLR8—Immune System—TYK2—systemic lupus erythematosus	3.65e-05	0.000335	CbGpPWpGaD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.65e-05	0.000311	CcSEcCtD
Imiquimod—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.64e-05	0.00031	CcSEcCtD
Imiquimod—Fatigue—Prednisone—systemic lupus erythematosus	3.63e-05	0.00031	CcSEcCtD
Imiquimod—Headache—Prednisolone—systemic lupus erythematosus	3.63e-05	0.00031	CcSEcCtD
Imiquimod—Discomfort—Methotrexate—systemic lupus erythematosus	3.63e-05	0.00031	CcSEcCtD
Imiquimod—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.6e-05	0.000307	CcSEcCtD
Imiquimod—Rash—Hydrocortisone—systemic lupus erythematosus	3.57e-05	0.000305	CcSEcCtD
Imiquimod—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.57e-05	0.000304	CcSEcCtD
Imiquimod—TLR7—Immune System—TLR4—systemic lupus erythematosus	3.55e-05	0.000326	CbGpPWpGaD
Imiquimod—Headache—Hydrocortisone—systemic lupus erythematosus	3.55e-05	0.000303	CcSEcCtD
Imiquimod—TLR7—Immune System—HLA-DRB1—systemic lupus erythematosus	3.55e-05	0.000326	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EP300—systemic lupus erythematosus	3.54e-05	0.000326	CbGpPWpGaD
Imiquimod—Dizziness—Triamcinolone—systemic lupus erythematosus	3.52e-05	0.000301	CcSEcCtD
Imiquimod—Dizziness—Methylprednisolone—systemic lupus erythematosus	3.52e-05	0.0003	CcSEcCtD
Imiquimod—Infection—Methotrexate—systemic lupus erythematosus	3.5e-05	0.000298	CcSEcCtD
Imiquimod—Feeling abnormal—Prednisone—systemic lupus erythematosus	3.47e-05	0.000296	CcSEcCtD
Imiquimod—Asthenia—Betamethasone—systemic lupus erythematosus	3.47e-05	0.000296	CcSEcCtD
Imiquimod—Asthenia—Dexamethasone—systemic lupus erythematosus	3.47e-05	0.000296	CcSEcCtD
Imiquimod—Nervous system disorder—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000295	CcSEcCtD
Imiquimod—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	3.44e-05	0.000294	CcSEcCtD
Imiquimod—Nausea—Prednisolone—systemic lupus erythematosus	3.44e-05	0.000294	CcSEcCtD
Imiquimod—Pruritus—Dexamethasone—systemic lupus erythematosus	3.42e-05	0.000292	CcSEcCtD
Imiquimod—Pruritus—Betamethasone—systemic lupus erythematosus	3.42e-05	0.000292	CcSEcCtD
Imiquimod—Skin disorder—Methotrexate—systemic lupus erythematosus	3.42e-05	0.000292	CcSEcCtD
Imiquimod—TLR8—Immune System—IFNG—systemic lupus erythematosus	3.42e-05	0.000314	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	3.4e-05	0.00029	CcSEcCtD
Imiquimod—Vomiting—Triamcinolone—systemic lupus erythematosus	3.39e-05	0.000289	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	3.39e-05	0.000311	CbGpPWpGaD
Imiquimod—Vomiting—Methylprednisolone—systemic lupus erythematosus	3.38e-05	0.000288	CcSEcCtD
Imiquimod—Nausea—Hydrocortisone—systemic lupus erythematosus	3.36e-05	0.000287	CcSEcCtD
Imiquimod—Rash—Triamcinolone—systemic lupus erythematosus	3.36e-05	0.000287	CcSEcCtD
Imiquimod—Dermatitis—Triamcinolone—systemic lupus erythematosus	3.36e-05	0.000286	CcSEcCtD
Imiquimod—Anorexia—Methotrexate—systemic lupus erythematosus	3.36e-05	0.000286	CcSEcCtD
Imiquimod—Rash—Methylprednisolone—systemic lupus erythematosus	3.35e-05	0.000286	CcSEcCtD
Imiquimod—Dermatitis—Methylprednisolone—systemic lupus erythematosus	3.35e-05	0.000286	CcSEcCtD
Imiquimod—Urticaria—Prednisone—systemic lupus erythematosus	3.35e-05	0.000285	CcSEcCtD
Imiquimod—Headache—Triamcinolone—systemic lupus erythematosus	3.34e-05	0.000285	CcSEcCtD
Imiquimod—Headache—Methylprednisolone—systemic lupus erythematosus	3.33e-05	0.000284	CcSEcCtD
Imiquimod—Abdominal pain—Prednisone—systemic lupus erythematosus	3.33e-05	0.000284	CcSEcCtD
Imiquimod—Body temperature increased—Prednisone—systemic lupus erythematosus	3.33e-05	0.000284	CcSEcCtD
Imiquimod—Diarrhoea—Dexamethasone—systemic lupus erythematosus	3.31e-05	0.000282	CcSEcCtD
Imiquimod—Diarrhoea—Betamethasone—systemic lupus erythematosus	3.31e-05	0.000282	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.31e-05	0.000304	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD4—systemic lupus erythematosus	3.3e-05	0.000303	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD80—systemic lupus erythematosus	3.28e-05	0.000301	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	3.25e-05	0.000298	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	3.21e-05	0.000274	CcSEcCtD
Imiquimod—Dizziness—Dexamethasone—systemic lupus erythematosus	3.2e-05	0.000273	CcSEcCtD
Imiquimod—Dizziness—Betamethasone—systemic lupus erythematosus	3.2e-05	0.000273	CcSEcCtD
Imiquimod—Insomnia—Methotrexate—systemic lupus erythematosus	3.18e-05	0.000272	CcSEcCtD
Imiquimod—Nausea—Triamcinolone—systemic lupus erythematosus	3.17e-05	0.00027	CcSEcCtD
Imiquimod—Paraesthesia—Methotrexate—systemic lupus erythematosus	3.16e-05	0.00027	CcSEcCtD
Imiquimod—Nausea—Methylprednisolone—systemic lupus erythematosus	3.16e-05	0.00027	CcSEcCtD
Imiquimod—Dyspnoea—Methotrexate—systemic lupus erythematosus	3.14e-05	0.000268	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	3.13e-05	0.000288	CbGpPWpGaD
Imiquimod—Somnolence—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000267	CcSEcCtD
Imiquimod—Hypersensitivity—Prednisone—systemic lupus erythematosus	3.1e-05	0.000265	CcSEcCtD
Imiquimod—TLR8—Immune System—CDKN1B—systemic lupus erythematosus	3.1e-05	0.000285	CbGpPWpGaD
Imiquimod—Dyspepsia—Methotrexate—systemic lupus erythematosus	3.1e-05	0.000264	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.09e-05	0.000284	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	3.08e-05	0.000283	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	3.08e-05	0.000283	CbGpPWpGaD
Imiquimod—Vomiting—Dexamethasone—systemic lupus erythematosus	3.07e-05	0.000262	CcSEcCtD
Imiquimod—Vomiting—Betamethasone—systemic lupus erythematosus	3.07e-05	0.000262	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—systemic lupus erythematosus	3.06e-05	0.000281	CbGpPWpGaD
Imiquimod—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000261	CcSEcCtD
Imiquimod—Rash—Dexamethasone—systemic lupus erythematosus	3.05e-05	0.00026	CcSEcCtD
Imiquimod—Rash—Betamethasone—systemic lupus erythematosus	3.05e-05	0.00026	CcSEcCtD
Imiquimod—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.05e-05	0.00026	CcSEcCtD
Imiquimod—Dermatitis—Betamethasone—systemic lupus erythematosus	3.05e-05	0.00026	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	3.04e-05	0.000259	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	3.04e-05	0.000279	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL2—systemic lupus erythematosus	3.04e-05	0.000279	CbGpPWpGaD
Imiquimod—Fatigue—Methotrexate—systemic lupus erythematosus	3.03e-05	0.000259	CcSEcCtD
Imiquimod—Headache—Betamethasone—systemic lupus erythematosus	3.03e-05	0.000258	CcSEcCtD
Imiquimod—Headache—Dexamethasone—systemic lupus erythematosus	3.03e-05	0.000258	CcSEcCtD
Imiquimod—Asthenia—Prednisone—systemic lupus erythematosus	3.02e-05	0.000258	CcSEcCtD
Imiquimod—Pain—Methotrexate—systemic lupus erythematosus	3.01e-05	0.000257	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	3.01e-05	0.000277	CbGpPWpGaD
Imiquimod—Pruritus—Prednisone—systemic lupus erythematosus	2.98e-05	0.000254	CcSEcCtD
Imiquimod—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000247	CcSEcCtD
Imiquimod—Diarrhoea—Prednisone—systemic lupus erythematosus	2.88e-05	0.000246	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.88e-05	0.000246	CcSEcCtD
Imiquimod—Nausea—Betamethasone—systemic lupus erythematosus	2.87e-05	0.000245	CcSEcCtD
Imiquimod—Nausea—Dexamethasone—systemic lupus erythematosus	2.87e-05	0.000245	CcSEcCtD
Imiquimod—TLR8—Immune System—CDKN1A—systemic lupus erythematosus	2.86e-05	0.000263	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	2.84e-05	0.000261	CbGpPWpGaD
Imiquimod—Urticaria—Methotrexate—systemic lupus erythematosus	2.8e-05	0.000239	CcSEcCtD
Imiquimod—Dizziness—Prednisone—systemic lupus erythematosus	2.79e-05	0.000238	CcSEcCtD
Imiquimod—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.78e-05	0.000237	CcSEcCtD
Imiquimod—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.78e-05	0.000237	CcSEcCtD
Imiquimod—TLR7—Immune System—TYK2—systemic lupus erythematosus	2.77e-05	0.000254	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EP300—systemic lupus erythematosus	2.72e-05	0.00025	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	2.7e-05	0.000248	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	2.7e-05	0.000248	CbGpPWpGaD
Imiquimod—Vomiting—Prednisone—systemic lupus erythematosus	2.68e-05	0.000228	CcSEcCtD
Imiquimod—Rash—Prednisone—systemic lupus erythematosus	2.66e-05	0.000227	CcSEcCtD
Imiquimod—Dermatitis—Prednisone—systemic lupus erythematosus	2.65e-05	0.000226	CcSEcCtD
Imiquimod—Headache—Prednisone—systemic lupus erythematosus	2.64e-05	0.000225	CcSEcCtD
Imiquimod—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.59e-05	0.000221	CcSEcCtD
Imiquimod—TLR7—Immune System—IFNG—systemic lupus erythematosus	2.59e-05	0.000238	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	2.56e-05	0.000235	CbGpPWpGaD
Imiquimod—Asthenia—Methotrexate—systemic lupus erythematosus	2.53e-05	0.000215	CcSEcCtD
Imiquimod—Nausea—Prednisone—systemic lupus erythematosus	2.5e-05	0.000213	CcSEcCtD
Imiquimod—TLR7—Immune System—CD4—systemic lupus erythematosus	2.5e-05	0.00023	CbGpPWpGaD
Imiquimod—Pruritus—Methotrexate—systemic lupus erythematosus	2.49e-05	0.000212	CcSEcCtD
Imiquimod—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.41e-05	0.000205	CcSEcCtD
Imiquimod—TLR7—Immune System—CDKN1B—systemic lupus erythematosus	2.35e-05	0.000216	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	2.35e-05	0.000216	CbGpPWpGaD
Imiquimod—Dizziness—Methotrexate—systemic lupus erythematosus	2.33e-05	0.000199	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—IL6—systemic lupus erythematosus	2.32e-05	0.000213	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL2—systemic lupus erythematosus	2.3e-05	0.000211	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	2.28e-05	0.000209	CbGpPWpGaD
Imiquimod—Vomiting—Methotrexate—systemic lupus erythematosus	2.24e-05	0.000191	CcSEcCtD
Imiquimod—Rash—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000189	CcSEcCtD
Imiquimod—Dermatitis—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000189	CcSEcCtD
Imiquimod—Headache—Methotrexate—systemic lupus erythematosus	2.21e-05	0.000188	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	2.19e-05	0.000201	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	2.19e-05	0.000201	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDKN1A—systemic lupus erythematosus	2.17e-05	0.000199	CbGpPWpGaD
Imiquimod—Nausea—Methotrexate—systemic lupus erythematosus	2.09e-05	0.000178	CcSEcCtD
Imiquimod—TLR7—Immune System—EP300—systemic lupus erythematosus	2.06e-05	0.00019	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—systemic lupus erythematosus	1.78e-05	0.000164	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.76e-05	0.000161	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—systemic lupus erythematosus	1.35e-05	0.000124	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.74e-06	8.03e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	6.94e-06	6.38e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.52e-06	5.07e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	5.36e-06	4.92e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.96e-06	4.56e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.34e-06	3.99e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	3.89e-06	3.58e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.61e-06	3.32e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	3e-06	2.76e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	2.46e-06	2.26e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	2.21e-06	2.03e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.11e-06	1.94e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	1.93e-06	1.78e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.9e-06	1.74e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.71e-06	1.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.63e-06	1.5e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	1.61e-06	1.48e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	1.49e-06	1.37e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.24e-06	1.14e-05	CbGpPWpGaD
